Topical Tranexamic Acid Found Inferior to Intravenous Administration
DAIC
APRIL 9, 2024
The trial, called DEPOSITION, intended to enroll 3,800 patients but stopped after enrolling 3,224 patients undergoing heart surgery at 16 sites in six countries. I think there is a message that is much broader than just cardiac surgery, in that we have to look at this drug with new eyes and new technologies to improve its performance.”
52 
Let's personalize your content